Feedback / Questions
Elrexfio (elranatamab-bcmm) - Pfizer
Elrexfio: Expiry of patents in US in 2036 with term extension until 2037
(Pfizer)
-
Mar 4, 2024 -
Annual Report 2023: Expiry of patents in EU/Japan in 2036
Patent
•
Hematological Malignancies • Multiple Myeloma • Oncology
https://d18rn0p25nwr6d.cloudfront.net/CIK-0000078003/1447e045-6320-4de3-a603-248c700cf342.pdf
Mar 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious